Exhibit 10.1
SECURITIES PURCHASE AGREEMENT
-----------------------------
THIS SECURITIES
PURCHASE AGREEMENT
(this "Agreement") dated as of July 28,
2004, by and among PROVECTUS PHARMACEUTICALS, INC., a Nevada corporation (the
"Company"), and the Buyers listed on
Schedule I attached hereto (individually, a
"Buyer" or collectively "Buyers").
WITNESSETH:
-----------
WHEREAS,
the Company and the
Buyer(s) are executing
and delivering
this
Agreement in reliance upon an exemption
from securities registration pursuant to
Section 4(2) and/or Rule 506 of Regulation
D ("Regulation D") as
promulgated by
the U.S. Securities and Exchange Commission
(the "SEC") under the Securities Act
of 1933, as amended (the "1933 Act");
WHEREAS,
the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell
to the Buyer(s),
as provided herein, and the Buyer(s) shall
purchase Seven Hundred Fifty Thousand
Dollars ($750,000) of secured convertible debentures (the "Convertible
Debentures"), which shall be convertible into shares of the Company's
common
stock, par value $0.001 per share (the "Common Stock") (as converted, the
"Conversion Shares"), of which Three Hundred Seventy Five Thousand Dollars
($375,000) shall be funded within five (5) business days hereof (the "First
Closing") and Three Hundred Seventy Five
Thousand Dollars
($375,000)
shall be
funded within five (5) business days after the filing of a registration
statement (the "Registration Statement") pursuant to the
Investor
Registration
Rights Agreement of even date herewith,
with the United States
Securities and
Exchange Commission (the "SEC") (the
"Second Closing") (collectively referred to
as the "Closings"), for a total purchase price of
Seven Hundred Fifty Thousand
Dollars ($750,000) (the "Purchase
Price") in the
respective amounts set
forth
opposite each Buyer(s) name on Schedule I
(the "Subscription Amount"); and
WHEREAS,
contemporaneously with
the execution and delivery of this
Agreement, the parties hereto are executing
and delivering a Registration Rights
Agreement substantially in the form attached
hereto as Exhibit A (the "Investor
Registration Rights Agreement") pursuant to which the Company has agreed to
provide certain registration rights under the 1933 Act and the rules and
regulations promulgated there under, and
applicable state securities laws; and
WHEREAS,
the aggregate proceeds
of the sale of the Convertible Debentures
contemplated hereby shall be held in escrow
pursuant to the terms
of an escrow
agreement substantially in the form of the
Escrow Agreement
attached hereto as
Exhibit B.
WHEREAS,
contemporaneously with
the execution and delivery of this
Agreement, the parties hereto are executing
and delivering Irrevocable Transfer
Agent Instructions substantially in the form attached
hereto as Exhibit C (the
"Irrevocable Transfer Agent
Instructions").
<PAGE>
WHEREAS,
contemporaneously with
the execution and delivery of this
Agreement, the parties hereto are executing
and delivering a Security Agreement
substantially in the form attached hereto as Exhibit D (the "Security
Agreement") pursuant to which the Company has agreed to provide the Buyer a
security interest in Pledged Collateral (as
this term is defined in the Security
Agreement dated the date hereof) to secure Company's obligations under this
Agreement, the Convertible Debenture, the Investor Registration Rights
Agreement, the Irrevocable Transfer Agent
Instructions, the
Security Agreement
or any other obligations of the Company to
the Buyer; and
NOW,
THEREFORE,
in consideration of the mutual covenants and other
agreements contained in this Agreement the
Company and the Buyer(s) hereby agree
as follows:
1. PURCHASE AND SALE OF CONVERTIBLE
DEBENTURES.
(a) Purchase of Convertible Debentures. Subject to the satisfaction
(or waiver) of the terms and conditions of this Agreement, each Buyer
agrees,
severally and not jointly, to purchase at Closing (as defined
herein
below) and the Company agrees to sell and issue to each Buyer,
severally and
not jointly, at
Closing, Convertible
Debentures in
amounts
corresponding with the
Subscription Amount
set forth opposite each Buyer's
name on
Schedule I hereto.
Upon execution hereof by a Buyer, the Buyer
shall wire
transfer the Subscription Amount set forth opposite his name
on
Schedule I in
same-day funds or a check payable to "Butler Gonzalez LLP, as
Escrow Agent for
Provectus Pharmaceuticals, Inc./Cornell Capital Partners,
LP",
which Subscription Amount shall be held in escrow
pursuant to the
terms of the
Escrow Agreement
(as hereinafter defined) and disbursed in
accordance
therewith.
Notwithstanding the foregoing, a Buyer may withdraw
his Subscription Amount and terminate this Agreement as to such Buyer
at
any time after
the execution
hereof and prior to
Closing (as
hereinafter
defined).
(b) Closing Date.
The First Closing of the purchase and sale
of the
Convertible
Debentures
shall take place on or before the fifth (5th)
business
day following the date hereof, subject to notification of
satisfaction of
the conditions to the First Closing set forth herein and in
Sections 6 and 7
below (or such later date as is mutually agreed to by the
Company and the
Buyer(s)) (the "First Closing Date") and the Second Closing
of the purchase
and sale of the Convertible Debentures shall take place on
or before the
fifth (5th) business day after the Registration Statement is
filed
with the SEC, subject to notification of satisfaction of the
conditions
to the Second
Closing set forth
herein and in Sections 6 and 7
below (or such
later date as is
mutually agreed to by
the Company and the
Buyer(s))
(the "Second Closing Date") (collectively referred to a the
"Closing
Dates"). The Closings
shall occur on the respective Closing Dates
at the offices
of Butler Gonzalez,
LLP, 1418 Morris Avenue, Suite 207,
Union,
NJ 07083 (or such other place as is mutually agreed to by the
Company and the
Buyer(s)).
(c) Escrow
Arrangements; Form of
Payment. Upon
execution hereof
by
Buyer(s) and
pending the Closings,
the aggregate
proceeds of the sale
of
the Convertible
Debentures to Buyer(s)
pursuant hereto shall
be deposited
in a
non-interest
bearing escrow account with Butler Gonzalez LLP, as
escrow
agent (the "Escrow Agent"), pursuant to the terms of an escrow
agreement
between the
Company, the Buyer(s) and the Escrow Agent in
the
form attached hereto as Exhibit B
(the "Escrow Agreement"). Subject to the
satisfaction of
the terms and conditions of this Agreement, on the Closing
2
<PAGE>
Dates, (i) the
Escrow Agent shall deliver to the Company in accordance with
the terms of the Escrow Agreement such aggregate proceeds for the
Convertible
Debentures
to be issued
and sold to such
Buyer(s), minus a
structuring
fee of $10,000 to the
Buyer pursuant to
Section 4(g)
hereof,
the ten percent
(10%) discount referenced in Section 4(g) hereof, and
$10,000
to the Buyer pursuant to Section 12.4 of the Standby Equity
Distribution
Agreement,
all of which shall be paid directly from the
proceeds
of the First Closing, all by wire transfer of immediately
available funds
in accordance with the Company's written wire instructions,
and (ii) the
Company shall deliver
to each Buyer,
Convertible
Debentures
which such
Buyer(s) is purchasing in amounts indicated opposite such
Buyer's name on
Schedule I, duly executed on behalf of the Company.
2. BUYER'S REPRESENTATIONS AND
WARRANTIES.
Each Buyer
represents and warrants, severally and not jointly, that:
(a) Investment
Purpose. Each Buyer is acquiring the Convertible
Debentures and,
upon conversion of Convertible Debentures, the Buyer will
acquire
the Conversion Shares then issuable, for its own account for
investment
only and not with a
view towards,
or for resale in
connection
with, the public
sale or distribution
thereof, except pursuant to sales
registered
or exempted under the 1933 Act; provided, however, that by
making the
representations herein, such Buyer reserves the right to
dispose
of the
Conversion Shares at
any time in accordance
with or pursuant to an
effective
registration
statement covering such Conversion Shares or an
available
exemption under the 1933 Act.
(b) Accredited Investor Status. Each Buyer is an "Accredited
Investor"
as that term is
defined in Rule 501(a)(3) of Regulation D.
(c) Reliance
on Exemptions. Each Buyer understands that the
Convertible Debentures are being offered and sold to it in reliance on
specific
exemptions
from the registration requirements of United States
federal and
state securities
laws and that the
Company is relying in part
upon the truth
and accuracy
of, and such
Buyer's compliance with, the
representations,
warranties, agreements, acknowledgments and understandings
of such Buyer
set forth herein in order to determine the availability of
such
exemptions
and the eligibility of such Buyer to acquire such
securities.
(d) Information.
Each Buyer and its advisors (and his or, its
counsel),
if any, have been
furnished with all
materials relating to
the
business,
finances and
operations of the Company and information he deemed
material to
making an informed
investment decision
regarding his purchase
of the
Convertible Debentures
and the Conversion
Shares, which have
been
requested by
such Buyer. Each Buyer
and its advisors,
if any, have been
afforded
the opportunity to ask questions of the Company and its
management.
Neither
such
inquiries
nor any other due diligence
investigations
conducted by such Buyer or its advisors, if any, or its
representatives
shall modify, amend or affect such Buyer's right to rely on
the Company's
representations and
warranties contained in Section 3 below.
Each Buyer
understands
that its investment in
the Convertible
Debentures
and the
Conversion Shares
involves a high degree of risk. Each Buyer is in
a position
regarding the Company,
which, based upon economic bargaining
3
<PAGE>
power,
enabled and enables such Buyer to obtain information from the
Company in order
to evaluate the merits and risks of this investment. Each
Buyer
has sought such accounting, legal and tax advice, as it has
considered
necessary to make an
informed investment
decision with respect
to its
acquisition of the Convertible Debentures and the Conversion
Shares.
(e) No Governmental
Review. Each Buyer understands that no United
States
federal or state
agency or any other
government
or governmental
agency
has passed on or made any recommendation or endorsement of the
Convertible
Debentures
or the Conversion Shares, or the fairness or
suitability
of the investment in the Convertible Debentures or the
Conversion
Shares, nor have such authorities
passed upon or
endorsed the
merits of the
offering of the
Convertible
Debentures
or the Conversion
Shares.
(f) Transfer or Resale. Each Buyer understands that except as
provided
in the Investor Registration Rights Agreement: (i) the Convertible
Debentures have
not been and are not being registered under the 1933 Act or
any state
securities laws, and may not be offered for sale, sold,
assigned
or transferred
unless (A) subsequently registered thereunder,
or (B) such
Buyer
shall have
delivered to the Company an opinion of counsel, in a
generally
acceptable
form, to the effect
that such securities to be sold,
assigned or
transferred may be sold, assigned or transferred pursuant to an
exemption
from such registration requirements; (ii) any sale of such
securities
made in reliance on
Rule 144 under the 1933 Act (or a successor
rule thereto)
("Rule 144") may be made only in accordance with the terms of
Rule 144 and
further, if Rule 144 is not applicable, any resale of such
securities
under circumstances in which the seller
(or the person through
whom the sale is
made) may be deemed to be an underwriter (as that term is
defined in the
1933 Act) may require
compliance with some
other exemption
under the 1933
Act or the rules and regulations of the SEC thereunder;
and
(iii)
neither the Company
nor any other person is under any obligation to
register such
securities under the 1933 Act or any state securities laws or
to comply with
the terms and
conditions of any exemption thereunder. The
Company reserves
the right to place stop transfer instructions against the
shares and
certificates for the Conversion Shares.
(g) Legends. Each
Buyer understands
that the certificates or other
instruments
representing the
Convertible Debentures
and or the Conversion
Shares shall
bear a restrictive
legend in substantially the following form
(and a stop
transfer order may be placed against transfer of such stock
certificates):
THE SECURITIES
REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE
SECURITIES
ACT OF 1933,
AS AMENDED, OR
APPLICABLE STATE
SECURITIES
LAWS. THE SECURITIES HAVE BEEN
ACQUIRED SOLELY
FOR INVESTMENT PURPOSES AND NOT WITH A VIEW
TOWARD RESALE AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT
FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL,
IN
A GENERALLY ACCEPTABLE
FORM, THAT
REGISTRATION IS NOT
REQUIRED
UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.
4
<PAGE>
The legend set
forth above shall be removed and the Company within two (2)
business days
shall issue a
certificate without
such legend to the holder
of the
Conversion
Shares upon which it
is stamped, if, unless
otherwise
required
by state securities laws, (i) in connection with a sale
transaction,
provided the
Conversion Shares are
registered under the 1933
Act or
(ii) in connection with a sale transaction, after such holder
provides the
Company with an opinion of counsel, which opinion shall be in
form,
substance and scope
customary for opinions
of counsel in comparable
transactions,
to the effect that a
public sale,
assignment or transfer of
the Conversion
Shares may be made without registration under the 1933 Act.
(h) Authorization,
Enforcement.
This Agreement has been duly and
validly
authorized, executed and delivered on behalf of such Buyer and is
a
valid and
binding agreement of
such Buyer enforceable
in accordance with
its terms, except as such enforceability may be limited by general
principles of
equity or applicable bankruptcy, insolvency, reorganization,
moratorium,
liquidation
and other similar laws relating to, or
affecting
generally, the
enforcement of applicable creditors' rights and remedies.
(i) Receipt
of Documents. Each Buyer and his or its counsel has
received
and read in their entirety: (i) this Agreement and each
representation,
warranty and covenant set forth herein, the Security
Agreement,
the Investor Registration Rights Agreement, the Escrow
Agreement,
and the Irrevocable
transfer Agent
Instructions; (ii) all
due
diligence
and other information necessary to verify the accuracy and
completeness of
such representations,
warranties and covenants; (iii) the
Company's
Form 10-KSB for the fiscal year ended
June 30, 2003;
(iv) the
Company's
Form 10-QSB for the
fiscal quarter ended
March 31, 2004 and (v)
answers to all
questions each Buyer
submitted to the Company regarding an
investment
in the Company; and each Buyer has relied on the
information
contained
therein
and has not been furnished any other documents,
literature,
memorandum or prospectus.
(j) Due Formation of Corporate and Other Buyers. If the Buyer(s) is a
corporation,
trust, partnership or other entity that
is not an individual
person,
it has been formed and
validly exists and has
not been organized
for the specific
purpose of purchasing
the Convertible
Debentures and is
not prohibited
from doing so.
(k) No Legal Advice From the Company. Each Buyer acknowledges, that
it
had the opportunity to review this Agreement and the transactions
contemplated
by this Agreement with his or its own legal counsel and
investment
and tax advisors.
Each Buyer is relying
solely on such counsel
and advisors and
not on any statements or representations of the Company or
any of its
representatives
or agents for legal,
tax or investment
advice
with respect to
this investment,
the transactions contemplated by this
Agreement or the
securities laws of any jurisdiction.
3. REPRESENTATIONS AND WARRANTIES OF
THE COMPANY.
The Company
represents and
warrants to each of the Buyers that, except as
set forth in the SEC Documents (as defined
herein):
5
<PAGE>
(a) Organization and Qualification. The Company and its subsidiaries
are
corporations duly organized and validly
existing in good standing under the laws
of the jurisdiction in which they are incorporated, and have the requisite
corporate power to own their properties and to carry on their business as
now
being conducted. Each of the Company and
its subsidiaries is duly qualified as a
foreign corporation to do business and is
in good standing in every jurisdiction
in which the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so
qualified or be in
good standing would not have a material
adverse effect on the Company and its
subsidiaries taken as a whole.
(b)
Authorization,
Enforcement, Compliance with Other Instruments. (i) The
Company has the requisite corporate power and authority to enter into and
perform this Agreement, the Security
Agreement, the Investor Registration Rights
Agreement, the Escrow Agreement, the Irrevocable Transfer Agent Instructions,
and any related agreements, and to issue the Convertible Debentures and the
Conversion Shares in accordance with the terms hereof and
thereof, (ii) the
execution and delivery of this Agreement,
the Security
Agreement, the
Investor
Registration Rights Agreement, the Escrow Agreement, the Irrevocable Transfer
Agent Instructions (as defined herein) and
any related agreements by the Company
and the consummation by it of the
transactions
contemplated hereby and thereby,
including, without limitation, the issuance of the Convertible
Debentures the
Conversion Shares and the reservation for issuance and the issuance of the
Conversion Shares issuable upon conversion
or exercise thereof,
have been duly
authorized by the Company's Board of Directors and no further consent or
authorization is required by the Company, its Board of Directors or its
stockholders, (iii) this Agreement, the Security Agreement, the Investor
Registration Rights Agreement, the Escrow Agreement, the Irrevocable Transfer
Agent Instructions and any related agreements have been duly executed and
delivered by the Company, (iv) this Agreement, the Security Agreement, the
Investor Registration Rights Agreement,
the Escrow Agreement,
the Irrevocable
Transfer Agent Instructions and any related
agreements constitute
the valid and
binding obligations of the Company
enforceable against the Company in accordance
with their terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws
relating to, or affecting generally, the
enforcement of creditors' rights and remedies. The authorized officer of the
Company executing this Agreement, the Security Agreement, the Investor
Registration Rights Agreement, the Escrow Agreement, the Irrevocable Transfer
Agent Instructions and any related
agreements knows of no reason why the Company
cannot file the registration statement as required under the Investor
Registration Rights Agreement or perform any of
the Company's other obligations
under such documents.
(c)
Capitalization. As of
the date hereof, the authorized capital stock of
the Company consists of 100,000,000 shares
of Common Stock, par value $0.001 per
share and 25,000,000 shares of Preferred Stock. As of
July 22, 2004, there were
14,555,446 shares of Common Stock, and no Preferred Stock issued and
outstanding. All of such outstanding shares have been validly
issued and are
fully paid and nonassessable. Except as disclosed in the SEC Documents (as
defined in Section 3(f)), no shares of Common Stock are
subject to
preemptive
rights or any other similar rights or any liens or
encumbrances
suffered or
permitted by the Company. Except as disclosed in the SEC
Documents and except
6
<PAGE>
for the securities to be issued
pursuant to that
certain Securities
Purchase
Agreement dated June 25, 2004 between the Company and certain accredited
investors, as of the date of this Agreement, (i) there are no outstanding
options, warrants, scrip, rights to subscribe to, calls or
commitments of any
character whatsoever relating to, or
securities or rights convertible into, any
shares of capital stock of the Company or
any of its subsidiaries, or contracts,
commitments, understandings or arrangements by which the
Company or any of its
subsidiaries is or may become bound to
issue additional
shares of capital stock
of the Company or any of its subsidiaries
or options, warrants, scrip, rights to
subscribe to, calls or commitments of any
character whatsoever
relating to, or
securities or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, (ii) there are no outstanding debt
securities and (iii) there are no
agreements or
arrangements
under which the
Company or any of its subsidiaries is obligated to register the sale
of any of
their securities under the 1933 Act (except
pursuant to the Registration Rights
Agreement); there are no outstanding
registration statements; and there are no
outstanding comment letters from the SEC or
any other regulatory agency, in each
case except as listed on Schedule 3(c) hereto. There are no securities or
instruments containing anti-dilution or similar provisions that will be
triggered by the issuance of the Convertible Debentures as described in this
Agreement. The Company has furnished to the
Buyer true and correct copies of the
Company's Articles of Incorporation, as amended and as in effect on the
date
hereof (the "Articles of Incorporation"), and the Company's By-laws, as in
effect on the date hereof (the "By-laws"), and the terms of all securities
convertible into or exercisable for Common
Stock and the material rights of the
holders thereof in respect thereto other
than stock options issued to employees
and consultants.
(d) Issuance of
Securities. The
Convertible Debentures are duly authorized
and, upon issuance in accordance with the terms hereof,
shall be duly
issued,
fully paid and nonassessable, are free from all taxes,
liens and charges
with
respect to the issue thereof. The Conversion Shares issuable
upon conversion of
the Convertible Debentures have been duly
authorized and reserved for issuance.
Upon conversion or exercise in accordance
with the Convertible Debentures the
Conversion Shares will be duly issued,
fully paid and nonassessable.
(e) No
Conflicts. Except as
disclosed in the SEC Documents, the execution,
delivery and performance of this Agreement,
the Security Agreement, the Investor
Registration Rights Agreement, the Escrow
Agreement and the Irrevocable Transfer
Agent Instructions by the Company and the
consummation
by the Company of
the
transactions contemplated hereby will not (i) result in a violation of the
Articles of Incorporation, any certificate of designations of any
outstanding
series of preferred stock of the Company or
the By-laws or (ii) conflict with or
constitute a default (or an event which with notice or lapse of time or
both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of
its subsidiaries is a party, or result
in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations
and the rules and
regulations of The National Association of Securities Dealers Inc.'s OTC
Bulletin Board on which the Common Stock is
quoted) applicable to the Company or
any of its subsidiaries or by which any
property or asset of the Company or any
of its subsidiaries is bound or affected. Except as disclosed in the SEC
Documents, neither the Company nor its
subsidiaries is in violation of any term
of or in default under its Articles of Incorporation or By-laws or their
7
<PAGE>
organizational charter or by-laws, respectively, or any material contract,
agreement, mortgage, indebtedness, indenture, instrument, judgment, decree
or
order or any statute, rule or regulation applicable to the Company or its
subsidiaries. The business of the Company
and its subsidiaries is not being
conducted, and shall not be conducted in violation of any material law,
ordinance, or regulation of any governmental entity. Except as specifically
contemplated by this Agreement and as required under the 1933 Act and any
applicable state securities laws, the Company is not required to obtain any
consent, authorization or order of, or make
any filing or registration with, any
court or governmental agency in order for
it to execute, deliver
or perform any
of its obligations under or contemplated by this
Agreement or the
Registration
Rights Agreement in accordance with the terms hereof or thereof. Except as
disclosed in the SEC Documents,
all consents,
authorizations,
orders, filings
and registrations which the Company is required to obtain pursuant to the
preceding sentence have been obtained or effected on or prior to the date
hereof. The Company and its subsidiaries are unaware of any facts or
circumstance, which might give rise to any
of the foregoing.
(f) SEC
Documents: Financial Statements. Since January 1, 2003, the
Company
has filed all reports, schedules, forms,
statements and other documents required
to be filed by it with the SEC under of the
Securities Exchange
Act of 1934, as
amended (the "1934 Act") (all of the
foregoing filed prior to the date hereof or
amended after the date hereof and all
exhibits included
therein and
financial
statements and schedules thereto and documents incorporated by reference
therein, being hereinafter referred to as
the "SEC Documents").
The Company has
delivered to the Buyers or their
representatives, or
made available through the
SEC's website at http://www.sec.gov., true and complete copies of the SEC
Documents. As of their respective dates,
the financial statements of the Company
disclosed in the SEC Documents (the
"Financial
Statements") complied as to form
in all material respects with applicable accounting requirements and the
published rules and regulations of the SEC
with respect thereto.
Such financial
statements have been prepared in accordance
with generally
accepted
accounting
principles, consistently applied, during
the periods involved (except (i) as may
be otherwise indicated in such Financial
Statements or the
notes thereto,
or
(ii) in the case of unaudited interim
statements, to the extent they may exclude
footnotes or may be condensed or summary
statements) and,
fairly present in all
material respects the financial
position of the
Company as of the dates thereof
and the results of its operations and cash flows for the
periods then ended
(subject, in the case of unaudited statements, to normal year-end audit
adjustments). No other information provided by or on behalf of the
Company to
the Buyer which is not included in the SEC Documents, including, without
limitation, information referred to in this Agreement, contains any untrue
statement of a material fact or omits to state any
material fact
necessary in
order to make the statements therein, in the light of the circumstances
under
which they were made, not misleading.
(g) 10(b)-5. The SEC Documents do not include any
untrue statements
of
material fact, nor do they omit to state
any material fact required to be stated
therein necessary to make the statements made, in light of the circumstances
under which they were made, not
misleading.
(h) Absence of
Litigation. Except as
disclosed in the SEC Documents, there
is no action, suit, proceeding, inquiry or
investigation before or by any court,
public board, government agency, self-regulatory organization or body pending
against or affecting the Company, the Common Stock or any of the Company's
subsidiaries, wherein an unfavorable decision,
ruling or finding would (i) have
a material adverse effect on the
transactions contemplated hereby (ii) adversely
affect the validity or enforceability of, or the authority or ability of the
8
<PAGE>
Company to perform its obligations under,
this Agreement or any of the documents
contemplated herein, or (iii) except as expressly disclosed in the SEC
Documents, have a material adverse effect on the business, operations,
properties, financial condition or results of
operations of the Company and its
subsidiaries taken as a whole.
(i) Acknowledgment Regarding Buyer's Purchase of the Convertible
Debentures. The Company acknowledges and agrees that the Buyer(s) is acting
solely in the capacity of an arm's length purchaser with respect to this
Agreement and the transactions contemplated hereby. The Company further
acknowledges that the Buyer(s) is not
acting as a financial advisor or fiduciary
of the Company (or in any similar
capacity) with respect to this Agreement
and
the transactions contemplated hereby and
any advice given by the Buyer(s) or any
of their respective representatives or agents in
connection with this Agreement
and the transactions contemplated hereby is merely incidental to such Buyer's
purchase of the Convertible Debentures or the Conversion
Shares. The Company
further represents to the Buyer that the
Company's decision to
enter into this
Agreement has been based solely on the
independent evaluation by the Company and
its representatives.
(j) No General Solicitation. Neither the Company, nor any of its
affiliates, nor any person acting on its or their
behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of
Regulation D under the 1933 Act) in connection with the offer or sale of the
Convertible Debentures or the Conversion
Shares.
(k) No
Integrated Offering. Neither the Company, nor any of its
affiliates,
nor any person acting on its or their
behalf has, directly
or indirectly,
made
any offers or sales of any security or
solicited any offers to buy any security,
under circumstances that would require registration of the Convertible
Debentures or the Conversion Shares under
the 1933 Act or cause this offering of
the Convertible Debentures or the Conversion
Shares to be integrated with prior
offerings by the Company for purposes of
the 1933 Act.
(l) Employee
Relations. Neither the
Company nor any of its subsidiaries is
involved in any labor dispute nor, to the
knowledge of the Company or any of its
subsidiaries, is any such dispute threatened. None of the Company's or its
subsidiaries' employees is a member of a union and the Company and its
subsidiaries believe that their relations
with their employees are good.
(m) Intellectual
Property Rights.
The Company and its
subsidiaries own or
possess adequate rights or licenses to use
all trademarks, trade
names, service
marks, service mark registrations, service names, patents, patent rights,
copyrights, inventions, licenses,
approvals, governmental authorizations, trade
secrets and rights necessary to conduct their respective businesses as now
conducted. The Company and its subsidiaries do not have any knowledge of any
infringement by the Company or its
subsidiaries of trademark, trade name rights,
patents, patent rights, copyrights,
inventions, licenses, service names, service
marks, service mark registrations, trade secret or other similar rights of
others, and, to the knowledge of the Company there is no claim, action or
proceeding being made or brought against,
or to the Company's
knowledge, being
threatened against, the Company or its
subsidiaries regarding
trademark, trade
name, patents, patent rights, invention, copyright, license, service names,
9
<PAGE>
service marks, service mark registrations,
trade secret or other
infringement;
and the Company and its subsidiaries are unaware of any facts or
circumstances
which might give rise to any of the
foregoing.
(n) Environmental Laws. The Company and its subsidiaries are (i) in
compliance with any and all applicable
foreign, federal, state and local laws
and regulations relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants or
contaminants ("Environmental Laws"), (ii)
have received all permits, licenses or
other approvals required of them under
applicable
Environmental Laws to conduct
their respective businesses and (iii) are in compliance with all terms and
conditions of any such permit, license or
approval.
(o) Title. Any
real property and facilities held under lease by the Company
and its subsidiaries are held by them under valid,
subsisting and
enforceable
leases with such exceptions as are not material and
do not interfere
with the
use made and proposed to be made of such
property and
buildings by the
Company
and its subsidiaries.
(p) Insurance. The Company and each of its
subsidiaries
are insured by
insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and
customary in the businesses in which the Company and its subsidiaries are
engaged. Neither the Company nor any such subsidiary has been refused any
insurance coverage sought or applied for and neither the Company nor
any such
subsidiary has any reason to believe that it will not be able to renew
its
existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its
business at a cost that would not
materially and adversely affect the condition,
financial or otherwise, or the earnings, business or operations of the
Company
and its subsidiaries, taken as a whole.
(q) Regulatory Permits. The Company and its subsidiaries possess all
material certificates, authorizations and permits issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct their
respective businesses, and neither the Company nor any such subsidiary has
received any notice of proceedings relating
to the revocation or modification of
any such certificate, authorization or
permit.
(r) Internal
Accounting Controls.
The Company and each of its subsidiaries
maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with
management's general or specific
authorizations, (ii)
transactions are recorded
as necessary to permit preparation of financial
statements in
conformity with
generally accepted accounting principles and to maintain asset
accountability,
and (iii) the recorded amounts for assets is compared
with the existing
assets
at reasonable intervals and appropriate action is taken with respect to
any
differences.
(s) No
Material Adverse Breaches, etc. Except as set forth in the SEC
Documents, neither the Company nor any of its subsidiaries is subject to any
charter, corporate or other legal
restriction, or any
judgment, decree, order,
rule or regulation which in the judgment of the
Company's officers has or is
expected in the future to have a material adverse effect on the business,
properties, operations, financial condition,
results of operations or prospects
of the Company or its subsidiaries. Except as set forth in the SEC
Documents,
10
<PAGE>
neither the Company nor any of its
subsidiaries is in
breach of any contract or
agreement which breach, in the judgment of the Company's
officers, has or is
expected to have a material adverse effect on the business, properties,
operations, financial condition, results of operations or prospects of the
Company or its subsidiaries.
(t) Tax Status.
Except as set forth in
the SEC Documents, the
Company and
each of its subsidiaries has made and filed
all federal and state income and all
other tax returns, reports and declarations required by any jurisdiction to
which it is subject and (unless and only to
the extent that the Company and each
of its subsidiaries has set aside on its
books provisions
reasonably
adequate
for the payment of all unpaid and
unreported taxes) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or
determined to be due on such returns, reports and declarations, except those
being contested in good faith and has set aside on its books provision
reasonably adequate for the payment of all
taxes for periods
subsequent to the
periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed
to be due by the taxing authority of
any jurisdiction, and the officers of the Company
know of no basis for any such
claim.
(u) Certain
Transactions.
Except as set forth in
the SEC Documents,
and
except for arm's length transactions pursuant to which the Company makes
payments in the ordinary course of business upon terms no
less favorable
than
the Company could obtain from third parties and other than the grant
of stock
options disclosed in the SEC Documents, none of the officers, directors, or
employees of the Company is presently a party to any transaction with the
Company (other than for services as employees, officers and directors),
including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any
officer,
director or such employee or, to the
knowledge of the Company, any corporation,
partnership, trust or other entity in which any
officer, director, or
any such
employee has a substantial interest or is an officer, director, trustee or
partner.
(v) Fees and
Rights of First Refusal. The Company is not obligated to offer
the securities offered hereunder on a right of
first refusal basis or otherwise
to any third parties including, but not limited to, current or former
shareholders of the Company, underwriters, brokers, agents or other third
parties.
4. COVENANTS.
(a) Best
Efforts. Each party
shall use its best efforts timely to satisfy
each of the conditions to be satisfied by it
as provided in Sections 6 and 7 of
this Agreement.
(b) Form D. The Company agrees to file a Form D with respect to the
Conversion Shares as required under
Regulation D and to
provide a copy thereof
to each Buyer promptly after such filing.
The Company shall,
on or before the
Closing Date, take such action as the Company
shall reasonably determine is
necessary to qualify the Conversion Shares, or obtain an exemption for the
Conversion Shares for sale to the Buyers at the Closing pursuant to this
Agreement under applicable securities or "Blue Sky" laws of
the states of the
United States, and shall provide evidence of any such action so
taken to the
Buyers on or prior to the Closing Date.
11
<PAGE>
(c) Reporting Status. Until the earlier of (i) the date as of
which the
Buyer(s) may sell all of the Conversion
Shares without
restriction pursuant
to
Rule 144(k) promulgated under the 1933 Act
(or successor
thereto), or (ii)
the
date on which (A) the Buyer(s) shall have
sold all the Conversion Shares and (B)
none of the Convertible Debentures are
outstanding (the "Registration Period"),
the Company shall file in a timely manner
all reports required
to be filed with
the SEC pursuant to the 1934 Act and the
regulations of the SEC thereunder, and
the Company shall not terminate its status
as an issuer required to file reports
under the 1934 Act even if the 1934 Act or
the rules and regulations thereunder
would otherwise permit such
termination.
(d) Use of
Proceeds. The Company will use the proceeds from the sale of
the
Convertible Debentures for general
corporate and working capital purposes.
(e) Reservation of Shares. The Company shall take all action
reasonably
necessary to at all times have authorized, and reserved for the purpose of
issuance, such number of shares of Common
Stock as shall be necessary to effect
the issuance of the Conversion Shares. If at any time the Company
does not have
available such shares of Common Stock as
shall from time to time be sufficient
to effect the conversion of all of the
Conversion
Shares of the Company
shall
call and hold a special meeting of the
shareholders
within thirty (30)
days of
such occurrence, for the sole purpose of increasing the number of shares
authorized. The Company's management shall
recommend to the shareholders to vote
in favor of increasing the number of shares of Common Stock authorized.
Management shall also vote all of its shares
in favor of increasing
the number
of authorized shares of Common Stock.
(f) Listings or
Quotation. The Company shall promptly secure the listing or
quotation of the Conversion Shares upon each national securities exchange,
automated quotation system or The National
Association of
Securities Dealers
Inc.'s Over-The-Counter Bulletin Board ("OTCBB") or other
market, if any, upon
which shares of Common Stock are then listed or quoted (subject to official
notice of issuance) and shall use its best efforts to
maintain, so long as
any
other shares of Common Stock shall be so
listed, such listing
of all Conversion
Shares from time to time issuable under the
terms of this Agreement. The Company
shall maintain the Common Stock's
authorization for quotation on the OTCBB.
(g) Fees and
Expenses. Each of the
Company and the Buyer(s) shall pay all
costs and expenses incurred by such party in
connection with the
negotiation,
investigation, preparation, execution and
delivery of this Agreement, the Escrow
Agreement, the Investor Registration Rights Agreement,
the Security
Agreement
and the Irrevocable Transfer Agent
Instructions. The
Buyer(s) shall be entitled
to a ten percent (10%) discount on the
Purchase Price.
On the First
Closing Date, the Company shall pay to the Buyer a structuring
fee of $10,000 (the "Structuring Fee"). The Structuring Fee shall be paid
directly from the gross proceeds of the First Closing and
shall be deemed fully
earned on the date hereof.
(h) Corporate Existence. So long as any of the Convertible Debentures
remain outstanding, the Company shall not directly or
indirectly consummate any
merger, reorganization, restructuring, reverse stock split consolidation,
sale
12
<PAGE>
of all or substantially all of the Company's assets or any
similar
transaction
or related transactions (each such transaction,
an "Organizational Change")
unless (i) prior to the consummation an Organizational Change, the Company
obtains the written consent of each Buyer
or (ii) all Convertible Debentures are
redeemed on or before the consummation of
the Organizational Change. In any such
case, the Company will make appropriate
provision with respect
to such holders'
rights and interests to insure that the provisions of this Section 4(h) will
thereafter be applicable to the Convertible
Debentures.
(i) Transactions
With Affiliates. So long as any Convertible Debentures are
outstanding, the Company shall not, and
shall cause each of its subsidiaries not
to, enter into, amend, modify or supplement, or permit any subsidiary to
enter
into, amend, modify or supplement any
agreement,
transaction,
commitment, or
arrangement with any of its or any
subsidiary's officers,
directors, person who
were officers or directors at any time during the previous two (2) years,
stockholders who beneficially own five
percent (5%) or more of the Common Stock,
or Affiliates (as defined below) or with any individual related by blood,
marriage, or adoption to any such individual or with any entity in which
any
such entity or individual owns a five
percent (5%) or more
beneficial
interest
(each a "Related Party"), except for (a) customary
employment
arrangements and
benefit programs on reasonable terms, (b) any investment in an
Affiliate of the
Company, (c) any agreement, transaction, commitment, or arrangement on an
arms-length basis on terms no less
favorable than terms which would have
been
obtainable from a person other than such Related Party, (d) any agreement
transaction, commitment, or arrangement which is approved
by a majority of the
disinterested directors of the Company, for
purposes hereof, any director who is
also an officer of the Company or any
subsidiary
of the Company shall
not be a
disinterested director with respect to any such agreement, transaction,
commitment, or arrangement. "Affiliate" for purposes hereof
means, with respect
to any person or entity, another person or entity that,
directly or indirectly,
(i) has a ten percent (10%) or more equity interest in that person or
entity,
(ii) has ten percent (10%) or more common
ownership with that
person or entity,
(iii) controls that person or entity,
or (iv) shares common
control with that
person or entity. "Control" or "controls" for purposes hereof means that a
person or entity has the power, direct or indirect, to conduct or govern the
policies of another person or entity. Notwithstanding the foregoing, this
Section shall not apply to transactions
between the Company and any wholly owned
subsidiary.
(j) Transfer
Agent. The Company covenants and agrees that, in the event
that the Company's agency relationship with the transfer agent should be
terminated for any reason prior to a date which is two (2) years after the
Closing Date, the Company shall immediately appoint a new transfer
agent and
shall require that the new transfer
agent execute and
agree to be bound by the
terms of the Irrevocable Transfer Agent
Instructions (as defined herein).
(k) Restriction on Issuance of the Capital Stock. So long as any
Convertible Debentures are outstanding, the
Company shall not, without the prior
written consent of the Buyer(s), issue or sell shares of Common Stock or
Preferred Stock (i) without consideration or for a
consideration per share less
than the Bid Price of the Common Stock determined immediately prior to its
issuance, (ii) any warrant, option, right, contract, call, or other security
instrument granting the holder thereof, the right to acquire Common Stock
without consideration or for a
consideration less
than such Common Stock's Bid
Price value determined immediately prior to
it's issuance, (iii)
enter into any
13
<PAGE>
security instrument granting the holder a security interest in any and all
assets of the Company, except that the
Compay may grant a security interest to a
lender that provides purchase money financing for inventory and
equipment and
such security interest relates solely to to the inventory and equipment so
purchased, or (iv) file any registration
statement on Form S-8,
except for the
Company's Amended and Restated 2002 Stock
Plan (which Plan shall not be modified
during the Commitment Period and provided that the
issuances under such Plan
comply with the other provisions of this
Section 6.8.
5. TRANSFER AGENT INSTRUCTIONS.
The Company
shall issue the Irrevocable Transfer Agent Instructions to
its
transfer agent irrevocably appointing Butler Gonzalez LLP as its agent for
purpose of having certificates issued,
registered in the name of the Buyer(s) or
its respective nominee(s), for the Conversion Shares
representing such amounts
of Convertible Debentures as specified from time
to time by the Buyer(s) to the
Company upon conversion of the Convertible Debentures, for interest owed
pursuant to the Convertible Debenture, and for any and all Liquidated
Damages
(as this term is defined in the Investor
Registration Rights Agreement). Butler
Gonzalez LLP shall be paid a cash fee of
Fifty Dollars ($50) for every occasion
they act pursuant to the Irrevocable
Transfer Agent
Instructions.
The Company
shall not change its transfer agent without
the express written
consent of the
Buyer(s), which may not be unreasonably
withheld if the
replacement
transfer
agent enters into the Irrevocable Transfer Agent Instructions. Prior to
registration of the Conversion Shares under the 1933 Act, all
such certificates
shall bear the restrictive legend specified in Section 2(g) of this
Agreement.
The Company warrants that no instruction
other than the
Irrevocable
Transfer
Agent Instructions referred to in this
Section 5, and stop transfer instructions
to give effect to Section 2(g) hereof (in the case of the
Conversion
Shares
prior to registration of such shares under the 1933 Act) will be given
by the
Company to its transfer agent and that the
Conversion Shares
shall otherwise be
freely transferable on the books and
records of the Company as and to the extent
provided in this Agreement and the Investor Registration Rights Agreement.
Nothing in this Section 5 shall affect in any way
the Buyer's
obligations and
agreement to comply with all applicable securities laws upon resale of
Conversion Shares. If the Buyer(s) provides the Company with an opinion of
counsel, in form, scope and substance customary for opinions of counsel in
comparable transactions to the effect that registration of a resale by the
Buyer(s) of any of the Conversion Shares is
not required under the 1933 Act, the
Company shall within two (2) business days
instruct its transfer
agent to issue
one or more certificates in such name and
in such denominations
as specified by
the Buyer. The Company acknowledges that a breach by it of its
obligations
hereunder will cause irreparable harm to the Buyer by vitiating the
intent and
purpose of the transaction contemplated hereby. Accordingly, the Company
acknowledges that the remedy at law for a
breach of its obligations under this
Section 5 will be inadequate and agrees,
in the event of a
breach or threatened
breach by the Company of the provisions of this Section 5, that the Buyer(s)
shall be entitled, in addition to all other
available remedies, to an injunction
restraining any breach and requiring
immediate issuance and transfer,
without
the necessity of showing economic loss and without any bond or other
security
being required.
6. CONDITIONS TO THE COMPANY'S
OBLIGATION TO SELL.
The obligation
of the Company
hereunder to issue and sell the Convertible
Debentures to the Buyer(s) at the Closings
is subject to the satisfaction, at or
before the Closing Dates, of each of the following
conditions,
provided that
14
<PAGE>
these conditions are for the Company's sole benefit and may be waived by
the
Company at any time in its sole
discretion:
(a) Each Buyer
shall have executed this Agreement, the Security Agreement,
the Escrow Agreement and the Investor Registration Rights Agreement and the
Irrevocable Transfer Agent Instructions and
delivered the same to the Company.
(b) The
Buyer(s) shall have delivered to the Escrow Agent the Purchase
Price for Convertible Debentures in
respective amounts as set forth next to each
Buyer as outlined on Schedule I attached
hereto and the Escrow
Agent shall have
delivered the net proceeds to the Company by wire transfer of immediately
available U.S. funds pursuant to the wire
instructions provided by the Company.
(c) The
representations
and warranties of the Buyer(s) shall
be true and
correct in all material respects as of the date when made
and as of the Closing
Dates as though made at that time
(except for
representations
and warranties
that speak as of a specific date), and the Buyer(s) shall have performed,
satisfied and complied in all material
respects with the
covenants,
agreements
and conditions required by this Agreement
to be performed, satisfied or complied
with by the Buyer(s) at or prior to the
Closing Dates.
7. CONDITIONS TO THE BUYER'S
OBLIGATION TO PURCHASE.
The obligation of the Buyer(s) hereunder to purchase the Convertible
Debentures at the Closing is subject to the satisfaction, at or before the
Closing Date, of each of the following
conditions:
(a) The Company
shall have executed this Agreement, the Security Agreement,
the Convertible Debenture, the Escrow Agreement, the Irrevocable Transfer
Instructions and the Investor Registration Rights Agreement,
and delivered the
same to the Buyer(s).
(b) The
Common Stock shall be authorized for quotation on the OTCBB,
trading in the Common Stock shall not have
been suspended for any reason and all
of the Conversion Shares issuable upon
conversion of the Convertible Debentures
shall be approved the OTCBB.
(c) The
representations
and warranties of the Company shall be true
and
correct in all material respects (except to the extent that any of such
representations and warranties is already
qualified as to materiality in Section
3 above, in which case, such representations and warranties shall be true and
correct without further qualification) as of the date when made and as of
the
Closing Dates as though made at that time (except for representations and
warranties that speak as of a specific date) and the Company shall have
performed, satisfied and complied in all
material respects with
the covenants,
agreements and conditions required by this
Agreement to be performed, satisfied
or complied with by the Company at or prior
to the Closing Dates.
If requested
15
<PAGE>
by the Buyer, the Buyer shall have received a certificate, executed by the
President of the Company, dated as of the
Closing Dates, to the foregoing effect
and as to such other matters as may be reasonably requested by the Buyer
including, without limitation an update as of the
Closing Dates
regarding the
representation contained in Section 3(c)
above.
(d) The Company
shall have
executed and delivered to the Buyer(s) the
Convertible Debentures in the respective amounts set forth opposite each
Buyer(s) name on Schedule I attached
hereto.
(e) The
Buyer(s) shall have received an opinion of counsel from the
Company's counsel in the form attached
hereto as Exhibit E.
(f) The Company
shall have provided to
the Buyer(s) a certificate of good
standing from the secretary of state from the state in which the
company is
incorporated.
(g) As of the
Closing Date,
the Company
shall have
reserved out of its
authorized and unissued Common Stock, solely for the purpose of
effecting the
conversion of the Convertible Debentures, shares of Common Stock to effect
the
conversion of all of the Conversion Shares
then outstanding.
(h) The
Irrevocable
Transfer Agent Instructions, in form and substance
satisfactory to the Buyer, shall have been delivered to and acknowledged in
writing by the Company's transfer
agent.
(i) The Company
shall have provided to the Buyer an acknowledgement, to the
satisfaction of the Buyer from _______ as
to its ability to provide all consents
required in order to file a registration statement in connection with this
transaction.
(j) The Company
shall have filed a form UCC-1 or such other forms as may be
required to perfect the Buyer's
interest in the
Pledged Property
and Pledged
Collateral as detailed in the Security Agreement dated the date hereof and
provided proof of such filing to the
Buyer(s).
(k) With
respect to the Second
Closing, the Company shall have filed a
registration statement with the SEC
pursuant to the Investor Registration Rights
Agreement of even date herewith.
8. INDEMNIFICATION.
(a) In consideration of the Buyer's execution and delivery of this
Agreement and acquiring the Convertible Debentures and the Conversion Shares
hereunder, and in addition to all of the
Company's other obligations under this
Agreement, the Company shall defend,
protect, indemnify and hold harmless
the
Buyer(s) and each other holder of the
Convertible Debentures
and the Conversion
Shares, and all of their officers,
directors,
employees and agents
(including,
without limitation, those retained in connection with the transactions
contemplated by this Agreement)
(collectively, the "Buyer Indemnitees") from and
against any and all actions, causes of action, suits, claims, losses, costs,
penalties, fees, liabilities and damages, and
expenses in connection therewith
(irrespective of whether any such Buyer
Indemnitee is a party to the action for
which indemnification hereunder is sought), and
including reasonable attorneys'
fees and disbursements (the "Indemnified Liabilities"), incurred by the Buyer
Indemnitees or any of them as a result of,
or arising out of, or relating to (a)
any misrepresentation or breach of any representation or warranty made by
the
Company in this Agreement, the Convertible Debentures or the Investor
16
Registration Rights Agreement or any other
certificate,
instrument or document
contemplated hereby or thereby, (b) any breach of any covenant, agreement or
obligation of the Company contained in this Agreement, or the Investor
Registration Rights Agreement or any other
certificate,
instrument or document
contemplated hereby or thereby, or (c) any cause of action, suit or claim
brought or made against such Indemnitee and
arising out of or resulting from the
execution, delivery, performance or enforcement of this
Agreement or any other
instrument, document or agreement executed pursuant hereto by any of the
Indemnities, any transaction financed or to be financed in whole or in
part,
directly or indirectly, with the proceeds of the
issuance of the
Convertible
Debentures or the status of the Buyer or
holder of the
Convertible
Debentures
the Conversion Shares, as a Buyer of
Convertible Debentures
in the Company. To
the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum
contribution to the
payment
and satisfaction of each of the
Indemnified
Liabilities, which is
permissible
under applicable law.
(b) In
consideration
of the Company's execution and delivery of this
Agreement, and in addition to all of the
Buyer's other
obligations under
this
Agreement, the Buyer shall defend, protect, indemnify and hold harmless the
Company and all of its officers,
directors,
employees and agents (including,
without limitation, those retained in connection with the transactions
contemplated by this Agreement)
(collectively,
the "Company
Indemnitees") from
and against any and all Indemnified
Liabilities
incurred by the
Indemnitees or
any of them as a result of, or arising out of, or relating to (a) any
misrepresentation or breach of any representation or warranty made by the
Buyer(s) in this Agreement, , instrument or document
contemplated
hereby or
thereby executed by the Buyer,
(b) any breach of any
covenant, agreement or
obligation of the Buyer(s) contained in this Agreement, the Investor
Registration Rights Agreement or any other
certificate,
instrument or document
contemplated hereby or thereby executed by the Buyer, or (c) any cause of
action, suit or claim brought or made
against such Company
Indemnitee based on
material misrepresentations or due to a material breach and arising out of or
resulting from the execution, delivery, performance or enforcement of this
Agreement, the Investor Registration Rights Agreement or
any other instrument,
document or agreement executed pursuant hereto by any of the Company
Indemnitiees. To the extent that the foregoing
undertaking by each Buyer may be
unenforceable for any reason, each Buyer
shall make the maximum
contribution to
the payment and satisfaction of each of the
Indemnified
Liabilities, which
is
permissible under applicable law.
9. GOVERNING LAW: MISCELLANEOUS.
(a) Governing
Law. This Agreement
shall be governed by and interpreted in
accordance with the laws of the State of New Jersey without regard to the
principles of conflict of laws. The parties further agree that any action
between them shall be heard in Hudson
County, New Jersey,
and expressly consent
to the jurisdiction and venue of the Superior Court of
New Jersey, sitting
in
Hudson County and the United States District Court for the District of New
Jersey sitting in Newark, New Jersey for the adjudication of any civil action
asserted pursuant to this Paragraph.
17
<PAGE>
(b) Counterparts. This Agreement may be executed in
two or more identical
counterparts, all of which shall be considered
one and the same
agreement and
shall become effective when counterparts have been signed by each party
and
delivered to the other party. In the event any signature page is delivered by
facsimile transmission, the party using such means of
delivery shall cause four
(4) additional original executed signature pages
to be physically
delivered to
the other party within five (5) days of the
execution and delivery hereof.
(c) Headings. The headings of this Agreement are for convenience of
reference and shall not form part of, or
affect the
interpretation
of, this
Agreement.
(d) Severability. If any provision of this Agreement
shall be invalid
or
unenforceable in any jurisdiction, such
invalidity or unenforceability shall not
affect the validity or enforceability of
the remainder of this Agreement in that
jurisdiction or the validity or enforceability of any provision of this
Agreement in any other jurisdiction.
(e) Entire
Agreement, Amendments. This Agreement supersedes all other
prior
oral or written agreements between the
Buyer(s), the Company,
their affiliates
and persons acting on their behalf with
respect to the matters discussed herein,
and this Agreement and the instruments referenced herein contain the entire
understanding of the parties with respect to the matters
covered herein and
therein and, except as specifically set forth herein or therein,
neither the
Company nor any Buyer makes any representation, warranty, covenant or
undertaking with respect to such matters.
No provision of this
Agreement may be
waived or amended other than by an
instrument in writing
signed by the party to
be charged with enforcement.
(f) Notices. Any notices, consents, waivers, or other communications
required or permitted to be given under the
terms of this
Agreement must be
in
writing and will be deemed to have been delivered (i) upon receipt, when
delivered personally; (ii) upon
confirmation of receipt, when sent by facsimile;
(iii) three (3) days after being sent by
U.S. certified
mail, return receipt
requested, or (iv) one (1) day after deposit with a nationally recognized
overnight delivery service, in each case properly addressed to the party to
receive the same. The addresses and facsimile
numbers for such
communications
shall be:
If to the Company, to: Provectus
Pharmaceuticals, Inc.
327 Oak Ridge Highway, Suite A
Knoxville, TN 37931
Attention:
Craig Dees
Telephone:
(865) 769-4011
Facsimile:
(865) 769-4013
With a copy to:
Baker, Donelson, Bearman, Caldwell & Berkowiz, P.C.
207 Mockingbird Lane
Post Office Box 3038 CRS
Johnson City, TN 37602
Attention:
Linda Crouch
Telephone:
(423) 928-0181
Facsimile:
(423) 928-5684
18
<PAGE>
If to the Transfer Agent, to: Atlas
Stock Transfer Corporation
5899 South State Street
Salt Lake City, UT 84107
Attention:
Pamela S. Gray
Telephone:
(801) 266-